Stockreport

Novo Nordisk A/S: More efficacious dose of Wegovy® recommended by the European Medicines Agency can help people with obesity achieve an average of 20.7% weight loss [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF In the STEP UP programme, people with obesity taking Wegovy ® 7.2 mg lost an average of 20.7% body weight at 72 weeks; one in three people achieved 25% or more weight l [Read more]